Severe cytomegalovirus-associated esophagitis in an immunocompetent patient after short-term steroid therapy

Journal of Clinical Microbiology

Volumn 47, Issue 9, 2009, Pages 3031-3033

  Weile, Jan ^a,c   Streeck, Benjamin ^b   Muck, Johannes ^b   Krebs, Gerd ^b   Jakobus, Karl Heinz ^b   Knabbe, Cornelius ^a   Weber, Friedhelm ^b  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b Rems Murr Klinik Schorndorf   (Germany)

^c DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CORTICOSTEROID; GANCICLOVIR;

ADULT; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; ESOPHAGITIS; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOCOMPETENCE; MALE; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SHORT COURSE THERAPY; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS; GANCICLOVIR; HUMANS; MALE; MIDDLE AGED; STEROIDS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 69949102244     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00143-09     Document Type: Article

References (12)

1. Altman, C., P. Bedossa, E. Dussaix, and C. Buffet. 1995. Cytomegalovirus infection of esophagus in immunocompetent adult. Dig. Dis. Sci. 40:606-608.
2. Arend, S. A., and A. C. M. Kroes. 2003. Look and ye shall find. . .cytomegalovirus infection in immunocompetent patients. Clin. Infect. Dis. 37:1607-1608.
3. Bonacini, M., T. Young, and L. Laine. 1991. The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. Arch. Intern. Med. 151:1567-1572.
4. Cohen, J. I., and G. R. Corey. 1985. Cytomegalovirus infection in the normal host. Medicine (Baltimore) 64:100-114.
5. Galiatsatos, P., I. Shrier, and E. Lamoureux. 2005. Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig. Dis. Sci. 50:609-616.
6. Gandhi, M. K., and R. Khanna. 2004. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect. Dis. 4:725-738.
7. Horwitz, C. A., W. Henle, G. Henle, D. Snover, H. Rudnick, H. H. Balfour, M. H. Mazur, R. Watson, B. Schwartz, and N. Muller. 1986. Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) 65:124-134.
8. Rafailidis, P., E. G. Mourtzoukou, I. C. Varbobitis, and M. E. Falagas. 2008. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol. J. 5:47.
9. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126. (Pubitemid 27431318)
10. Venkataramani, A., A. J. Schlueter, T. J. Spech, and E. Greenberg. 1994. Cytomegalovirus esophagitis in an immunocompetent host. Gastrointest. Endosc. 40:392-393.
11. Wiest, P. M., T. Flanigan, R. A. Salata, D. M. Shlaes, M. Katzman, and M. M. Lederman. 1989. Serious infectious complications of corticosteroid therapy for COPD. Chest 95:1180-1184. (Pubitemid 19160135)
12. Wilcox, C. M., D. L. Diehl, J. P. Cello, W. Margaretten, and M. A. Jacobson. 1990. Cytomegalovirus esophagitis in patients with AIDS. A clinical, endoscopic, and pathologic correlation. Ann. Intern. Med. 113:589-593.